Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa L Fishel

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|May 14, 2008
DNA repair proteins as molecular targets for cancer therapeuticsMark R Kelley, Melissa L Fishel
Molecular Aspects of Medicine|June 15, 2007
The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive targetMelissa L Fishel, Mark R Kelley
Antioxidants & Redox Signaling|August 22, 2008
Going ape as an approach to cancer therapeuticsAditi Bapat, Melissa L Fishel, Mark R Kelley
Future Oncology (London, England)|June 21, 2014
Targeting DNA repair pathways for cancer treatment: what's new?Mark R Kelley, Derek Logsdon, Melissa L Fishel
Journal of Medicinal Chemistry|January 7, 2014
Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cellsBibek Parajuli, Melissa L Fishel, Thomas D Hurley
Seminars in Cell & Developmental Biology|February 11, 2016
STAT3 in the systemic inflammation of cancer cachexiaTeresa A Zimmers, Melissa L Fishel, Andrea Bonetto
Mutation Research|August 2, 2006
DNA repair in neurons: so if they don't divide what's to repair?Melissa L Fishel, Michael R Vasko, Mark R Kelley
Future Oncology (London, England)|June 13, 2009
Small-molecule inhibitors of proteins involved in base excision repair potentiate the anti-tumorigenic effect of existing chemotherapeutics and irradiationApril M Reed, Melissa L Fishel, Mark R Kelley
Current Molecular Pharmacology|November 30, 2011
APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1Mark R Kelley, Millie M Georgiadis, Melissa L Fishel
Frontiers in Oncology|November 4, 2021
Clinical and Preclinical Outcomes of Combining Targeted Therapy With RadiotherapyMay Elbanna, Nayela N Chowdhury, Ryan Rhome, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Anti-Cancer Agents in Medicinal Chemistry|May 14, 2008
DNA repair proteins as molecular targets for cancer therapeuticsMark R Kelley, Melissa L Fishel
Molecular Aspects of Medicine|June 15, 2007
The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive targetMelissa L Fishel, Mark R Kelley
Antioxidants & Redox Signaling|August 22, 2008
Going ape as an approach to cancer therapeuticsAditi Bapat, Melissa L Fishel, Mark R Kelley
Future Oncology (London, England)|June 21, 2014
Targeting DNA repair pathways for cancer treatment: what's new?Mark R Kelley, Derek Logsdon, Melissa L Fishel
Journal of Medicinal Chemistry|January 7, 2014
Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cellsBibek Parajuli, Melissa L Fishel, Thomas D Hurley
Seminars in Cell & Developmental Biology|February 11, 2016
STAT3 in the systemic inflammation of cancer cachexiaTeresa A Zimmers, Melissa L Fishel, Andrea Bonetto
Mutation Research|August 2, 2006
DNA repair in neurons: so if they don't divide what's to repair?Melissa L Fishel, Michael R Vasko, Mark R Kelley
Future Oncology (London, England)|June 13, 2009
Small-molecule inhibitors of proteins involved in base excision repair potentiate the anti-tumorigenic effect of existing chemotherapeutics and irradiationApril M Reed, Melissa L Fishel, Mark R Kelley
Current Molecular Pharmacology|November 30, 2011
APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1Mark R Kelley, Millie M Georgiadis, Melissa L Fishel
Frontiers in Oncology|November 4, 2021
Clinical and Preclinical Outcomes of Combining Targeted Therapy With RadiotherapyMay Elbanna, Nayela N Chowdhury, Ryan Rhome, et al.
Pageof 9